Collaborative Efforts with Clients and Partners are Key for Making the Digital Disruption in Healthcare a Reality Helsinki, Finland &...
Results to be presented during the developmental immunotherapy and tumor immunobiology session at the American Society of Clinical Oncology (ASCO)...
Results to be presented during the cancer prevention, hereditary genetics and epidemiology session at the ASCO 2019 Annual Meeting CHICAGO,...
New Enhancements Advance Medical Device Interoperability and Clinician Productivity; Two Critical Components for Reducing Errors and Streamlining Processes within Healthcare...
Members of the NantHealth Connected Care Team to Participate in Several Presentations Regarding Medical Device Integration and Interoperability Gothenburg, Sweden...
Total revenue in Q1 was $23.7 million, up 7% from Q1 2018 SaaS revenue of $17.8 million in Q1, up...
CULVER CITY, Calif.–(BUSINESS WIRE)–May 2, 2019– NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report...
Culver City, CA and Las Vegas, NV – April 10, 2019 – NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company,...
Total Revenue in Q4 was $22.9 Million SaaS revenue of $17.3 million in Q4, up 9% from Q3 Enhanced efficiencies continued to drive...
CULVER CITY, Calif.–(BUSINESS WIRE)–Mar. 25, 2019– NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report...
Culver City, CA – March 18, 2019 – NantHealth, Inc. (NASDAQ: NH),announced an agreement with Northwest Fire Fighters Benefits Trust (NWFFT), one...
Findings to be presented at the 2019 American Society of Clinical Oncology’s Genitourinary Cancers Symposium San Francisco and Culver City,...